BioCentury | Aug 22, 2016
Company News

Protagen, Werfen deal

...Protagen granted Werfen’s Inova Diagnostics Inc. company semi-exclusive rights to develop and commercialize biomarker bicaudal D homolog 2 (BICD2)...
BioCentury | Jun 20, 2016
Company News

Protagen sales and marketing update

...Protagen launched its Multilisa CENP-B, Multilisa Scl-70 and Multilisa BICD2 ELISA assays to diagnose systemic sclerosis...
...serum and plasma. Multilisa BICD2 is a semi-quantitative test to determine IgG antibodies for the bicaudal D homolog 2 (BICD2)...
BioCentury | Sep 1, 2014
Company News

Protagen sales and marketing update

...platform to detect autoantibody levels of topoisomerase I (TOP1) , centromere protein B (CENPB) , bicaudal D homolog 2 (BICD2)...
Items per page:
1 - 3 of 3